We recently published a list of 10 AI Stocks Investors are Watching Closely. In this article, we are going to take a look at ...
Despite the strong performance seen in 2024, Wall Street equity researchers have remained quite bearish on Palantir stock.
Cantor Fitzgerald issued their FY2025 earnings estimates for Pliant Therapeutics in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will ...